No.

Company Name
1 Dr. Reddy's Laboratories Limited
2 Tata Motors
3 Sun Pharmaceutical
4 Cipla
5 Mahindra & Mahindra
6 Larsen & Toubro (L&T)
7 Taj Hotels
8 Aditya Birla Group
9 Reliance Industries
10 Wockhardt
11 Bharat Forge
12 Godrej Group
13 Dabur
14 Zoom Cars

15 JSW Steel
16 Tata Steel

17 Uflex
18 Jindal Poly Films
19 Jubilant Radiopharma
20 Samvardhana Motherson Group
21 Polyplex
22 QuEST
23 Sundaram Clayton
24 Novelis : Hindalco
25 Surya Carpet
26 Lupin Pharmaceuticals
27 Jain Irrigation Systems Ltd
28 Matrix Comsec
29 Sarla Performance Fibers
30 Himatsingka Seide
31 United Phosphorus
32 Woodfield Systems
33 Indian Toners
34 Pidilite
35 Piramal Healthcare
36 Setco Automotive
37 Epsilon Advanced Materials
38 Aurobindo Pharma Limited
39 Elgi Equipment Limited
40 Colourtex
41 Suzlon Energy
42 Strides Arcolab Ltd
43 Glenmark Pharmaceuticals
44 Torrent Pharmaceuticals
45 TATA consumer products
46 INDO-MIM
47 Essar Group
48 Marksans Pharma
49 Enzene Biosciences
50 Vikram Solar
51 Thermax Limited
52 NALCO (National Aluminium Company)
53 Atul Limited
54 Vinati Organics
55 Deepak Nitrite
56 KEC International Ltd
57 Mankind Pharmaceuticals
58 Welspun Corp
59 RAIN Industries Limited
60 Apollo Tyres
61 Kirloskar Brothers Limited
62 Alkem Laboratories
63 Waaree Energies
64 Biocon
65 Emcure Pharmaceuticals
66 Zydus
67 Havells India
68 Natco Pharmaceuticals
69 BKT Tires
70 Eicher Motors
71 Granules Pharmaceuticals

72 Sterlite
73 Divi's Laborateries
74 Galaxy Surfactants
75 Gujarat Fluorochemicals

76 Anupam Rasayan India

77 Meghmani Organics Ltd
78 Sona BLW Precision Forgings Ltd.
79 Vardhman Textiles Ltd

80 Indo Count Industries Ltd.

81 Alembic Pharmaceuticals Ltd.
82 Neuland Laboratories Ltd.
83 Carborundum Universal Ltd
84 IFGL Refractories Ltd.
85 Jaipur Living Inc
86 Uniparts India Limited
87 Siddhi Integrated Manufacturing Services
88 Essel Propack

89 The Hi-Tech Gears

90 Sanmar Group
91
92
93
94 Cadila Pharmaceuticals Ltd.
95 Indian Oil Corporation
96 Exide Industries
97 UNO Minda Group
98 Gland Pharmaceuticals
99 GreenKo Energy Holdings
100
 Industry / Sector Headquarters (India)
Pharmacuetical Hyderabad
Automotive Mumbai
Pharmacuetical Mumbai
Pharmacuetical Mumbai
Automotive Mumbai
Engineering, Construction Mumbai
Hospitality Mumbai
Metal, Cement Mumbai
Energy, Retail Mumbai
Pharmacuetical Mumbai
Automotive, Aerospace Pune
Consumer Goods, Engineering Mumbai
FMCG Ghaziabad
Car Sharing Banglore

Steel Mumbai
Steel Mumbai

Packaging Noida
Manufacturing Vasant Kunj, Delhi
Pharmacuetical Noida
Automotive Noida
Packaging Noida
Engineering Banglore
Automotive Chennai
Recycling Mumbai
Textiles Bhadohi, UP
Pharmacuetical Mumbai
Agriculture Jalgoan, Maharastra
Security and Telecommunications Vadodara, Gujarat
Textiles Mumbai
Textiles Banglore
Agrochemicals Mumbai
Engineering and Manufacturing Mumbai
Chemicals Rampur, UP
Chemicals Mumbai
Pharmacuetical Mumbai
Automotive Mumbai
Battery Manufacturing Banglore
Pharmacuetical Hyderabad
Industrial Equipment Coimbatore, Tamil Nadu
Chemicals Surat, Gujrat
Renewable Energy Pune
 Pharmacuetical Banglore
Pharmacuetical Mumbai
Pharmacuetical Ahemdabad
FMCG Mumbai
Precision Engineering Banglore
Steel, Energy Mumbai
Pharmacuetical Mumbai
Biopharmaceuticals Pune
Solar Energy Kolkata
Energy/Environmental solutions Pune
Aluminium Production Odisha
Chemicals Gujarat
Chemicals Mumbai
Chemicals Gujarat
Engineering, Infrastructure Mumbai
Pharmacuetical Delhi
Steel pipes Mumbai
Chemicals Hyderabad
Tires Gurugram
Pumps, Industrial Equipment Pune
Pharmacuetical Mumbai
Solar Energy Mumbai
Biopharmaceuticals Bengaluru
Pharmacuetical Pune
Pharmacuetical Gujarat
Electrical Equpiment Noida
Pharmacuetical Hyderabad
Tires Mumbai
Automotive Delhi
Pharmacuetical Hyderabad

Metals & Mining Mumbai

Pharmacuetical Hyderabad
Chemicals Mumbai
Industrial Refrigerant Noida

Chemicals Gujarat
Chemicals Gujarat
Auto components Gurugram
Textiles Punjab

Textiles Mumbai
Pharmacuetical Gujarat
Pharmacuetical Hyderabad
Engineering Chennai
 Refractories Odisha
Textiles Rajasthan
Engineering Noida
Manufacturing Gujrat
Packaging Mumbai

Automotive Gurugram
Engineering Chennai, Tamil Nadu

Pharmacuetical Gujarat
Oil & Gas Delhi
Automotive batteries Kolkata
Automotive components Gurugram
Pharmacuetical Hyderabad
Renewable Energy Hyderabad
 Location (Foreign) Year of Establishment
Princeton, New Jersey 1984
Washington,DC 1945
Princeton, New Jersey 1983
Warren, New Jersey 1935
Houston,texas 1945
Houston,texas 1938
New York 1903
Florence, KY 1857
Delaware 1957
Parsippany, NJ 1967
Lansing, MI 1961
Atlanta, Georgia 1897
Princeton, New Jersey 1884
California 2013
Mingo Junction, Ohio
Baytown, Texas 1982
Schaumburg, IL 1907
Kentucky
New Jersey 1985
Okloma 1974
Yardley, Pennsylvania 1978
Troy, Michigan 1975
Decatur, Alabama 1984
East Hartford, Connecticut 1997
South Carolina 1962
Atlanta, Georgia 2005
White, Georgia 1976
Baltimore, Maryland 1983
Fresno, California 1986
Orange, CA 1991
South Carolina 1993
New York 1985
King of Prussia, Pennsylvania 1969
Houston,texas 2000
Florida 1990
Jupiter, Florida 1959
Bethlehem, Pennsylvania 1988
Paris, Tennessee 1982
North Carolina 2014
East Windsor, New Jersey 1986
Charlotte, North Carolina 1960
Charlotte, North Carolina 1976
Chicago, Illinois 1995
East Brunswick, New Jersey 1990
Mahwah, New Jersey 1977
Basking Ridge, New Jersey 1959
Connecticut 1964
Texas 1997
Minnesota 1969
New Jersey 1992
Hopewell, New Jersey 2019
Delaware 2006
New Jersey 1966
Naperville, Illinois 1981
Noth Carolina 1947
Delaware 1989
Noth Carolina 1970
Texas 1945
New Jersey 1995
Texas 1995
Connecticut 1974
Georgia 1972
Illinois 1888
New Jersey 1973
Texas 1989
New Jersey 1978
New Jersey 1983
New Jersey 1952
New York 1958
New Jersey 1981
Ohio 1987
Wisconsin 1948
Virginia 1991

Delaware, South Carolina 1975

New Jersey 1990
New Jersey 1980
Texas 1987

Delaware 1984
North Carolina 1986
1995
1965
New York
North Carolina 1988
New Jersey 1907
New Jersey 1984
1954
 Ohio
Michigan 1979
Georgia 1978
Iowa 1984
Clarksville, Indiana 2011
Danville, Virginia 1995

Emporium, PA 1986
Texas 1972

Washington DC 1951
1964
Georgia 1947
1958
1978
Texas 2004
Year Entered US Market Type of Entry
1994 Exports, Acquisitions,(Subsidiary)
1945 Subsidiary
1997 Acquisitions, Subsidiary
1984 Subsidiary
1994 Subsidiary
1945 Distributor/ Subsidiary
2005 Acquisition
2007 Acquisitions, Subsidiary
2005 Joint Venture, Subsidiary
2000 Joint Venture, Subsidiary
1962 Subsidiary
1990 Acquisition, Strategic Alliances
2005 Acquisition
2023 Merger

2007 Brownfield Investment

1990 Joint Venture, Subsidiary

1989 Subsidiary
2013 Acquisition, Subsidiary
2008 Joint Venture, Subsidiary
2000 subsidiary
2004 subsidiary
1997
2019
2005 Subsidiary
1986 Subsidiary
2003 Acquisition, Subsidiary
2006 Acquisition
1998 subsidiary
2013 Subsidiary
2005 Subsidiary
2006 Subsidiary
2010 Subsidiary
2016 Subsidiary
2006 Subsidiary
2009 Acquisition
2005 Acquisition
2018 Subsidiary
2004 Subsidiary
2001 Joint Venture, Subsidiary
2005 Subsidiary
2001 Subsidiary
2004 Subsidiary
2005 Subsidiary
2003 Subsidiary, Acquisition
1987 Subsidiary
2017 Joint Venture, Subsidiary
2007 subsidiary
2015 Subsidiary, Acquisition
2024 Subsidiary
2018 Subsidiary
2001 Subsidiary
1994 Joint Venture, Subsidiary
1994 Subsidiary
2025 Subsidiary
2014 Subsidiary
2010 Acquisition
2015 Subsidiary
2009 Subsidiary
2006 Subsidiary
2009 Subsidiary
2015 Subsidiary
2010 Subsidiary
Subsidiary
2015 Subsidiary
1991 Subsidiary
2003 Subsidiary
Subsidiary, Acquisition
Subsidiary
1995 Subsidiary
2005 Distribution, Subsidiary
2003 Subsidiary

2023 Subsidiary
2006 Subsidiary
2009 Subsidiary
2009 Subsidiary

2024 Subsidiary
Subsidiary
Subsidiary
Joint venture

Subsidiary
2015 Subsidiary
2004 Subsidiary
2007 Subsidiary
2005 Subsidiary
Subsidiary
2005 Subsidiary
2021 Subsidiary
2002 Subsidiary
Partnership with getrag/
2000 Acquisition
2000 Partnership/ Acquisition

Subsidiary

Greenfield Investment
Total Investment in the USD (FDI, Capex, R&D, M&A)
Not disclosed
Not disclosed
$567 Million for acquisition + $15 million in pharmazz
$550 Million in acquisition in 2015
$ 1 Billion
Not disclosed
Not disclosed
More than $15 Billion
Not disclosed
Not disclosed
More than $100 Million
Not disclosed
Not disclosed

Not disclosed
₹ 3.7 Billion for plant

$180 Million in 2011

$10 Billion
$100 Million
$100 Million
$48 million for acquisition
Not disclosed
$13.8 million for setting up manufacturing facility
$30 million for acquisition
$36 million for acquisition
$1.5 million
$30,000
$1 Million
$635 million in 2012
$5 Million
$635 million in plant
$50 million
$450 Million
Not disclosed
$1.28 Billion
 $42 Million on Manufacturing Facility
More than $100 Million
Not disclosed
$30,000
$30 Million for Manufacturing Facility
$650 million in manufacturing plant + $ 1.7 billion
Not disclosed
$ 50 Million
$1.5 Billion in new factories

N/A

$ 95 Million for Acquisition

₹ 300 Crore in a manufacturing Plant
₹ 2.66 Billion

₹ 590.58 Million

$3.34 billion

₹ 207 Million

$100 million in new manufacturing facility

No major investment

₹ 56 Million for manufacturing unit

₹ 1.73 Billion

Capital investment of ₹ 0.87 Million

 $ 8.77 million
Not Disclosed
$ 15 million for manufacturing plant

$ 58 Million for acquisition of component manufacturer

₹ 147 Crore in a Steel Business Company
 Annual Revenue from US Operations
FY 2022 FY 2023 FY 2024
₹ 74.915 Billion ₹ 101.7 Billion ₹ 129.9 Billion
₹ 455.13 Billion ₹ 547.7 Billion ₹ 674.96 Billion
₹ 114 Billion ₹ 135 Billion ₹ 153.5 Billion
NA ₹ 63.3 Billion ₹ 78.6 Billion
NA NA ₹ 5 Billion
₹ 700 Billion - estimated ₹ 900 Billion - estimated ₹ 1000 Billion - estimated
₹ .23 Billion ₹ .78 Billion ₹ .94 Billion
NA NA NA
Not disclosed Not disclosed Not disclosed
Not disclosed Not disclosed Not disclosed
Not disclosed Not disclosed ₹ 2.6 Billion
Not disclosed Not disclosed Not disclosed

Not disclosed Not disclosed Not disclosed

₹ 8.29 Billion

₹ 17.51 Billion ₹ 19.19 Billion ₹ 17.68 Billion

Not disclosed Not disclosed Not disclosed

₹ 113.4 Billion ₹ 140.1 Billion ₹ 176.1 Billion

₹ 500.43 Billion ₹ 569.46 Billion ₹ 493.9 Billion

Not disclosed Not disclosed Not disclosed
Not disclosed Not disclosed Not disclosed
Not disclosed Not disclosed Not disclosed
Not disclosed Not disclosed Not disclosed
₹ .431 Billion ₹ .387 Billion ₹ .38 Billion
₹ 28.2 Billion ₹ 21.2 Billion ₹ 22.01 Billion
₹ 40.8 Billion ₹ 48.8 Billion ₹ 38.93 Billion
Not disclosed Not disclosed Not disclosed
Not disclosed Not disclosed Not disclosed
₹ 0.45 Billion ₹ 0.36 Billion ₹ 0.34 Billion
₹ 18.4 Billion ₹ 21.4 Billion ₹ 24.6 Billion
₹ 0.54 Billion ₹ 0.60 Billion ₹ 0.63 Billion
Not disclosed Not disclosed Not disclosed
₹ 112.34 Billion ₹ 128.27 Billion ₹ 138.27 Billion
Not disclosed Not disclosed Not disclosed
Not disclosed Not disclosed Not disclosed
₹ 0.58 Billion ₹ 0.6 Billion ₹ 0.97 Billion
 ₹ 16.6 Billion ₹ 18.2 Billion ₹ 20.24 Billion
₹ 32.5 Billion ₹ 31.48 Billion ₹ 30.93 Billion
₹ 10.67 Billion ₹ 11.7 Billion ₹ 10.8 Billion
₹ 17.13 Billion ₹ 18.76 Billion ₹ 20.98 Billion
Not disclosed Not disclosed Not disclosed
Not disclosed Not disclosed Not disclosed
₹ 6.31 Billion ₹ 7.78 Billion ₹ 9.18 Billion
Not disclosed Not disclosed Not disclosed
₹ 7.34 Billion ₹ 10 Billion ₹ 13.34 Billion
₹ 1.61 Billion ₹ 2.45 Billion ₹ 1.92 Billion

₹ 4.201 Billion ₹ 5.764 Billion ₹ 3.707 Billion

N/A N/A N/A
₹ 1. 45 Million ₹ 1. 47 Million ₹ 1. 63 Million
₹ 8.25 Billion ₹ 10.36 Billion ₹ 11.95 Billion
₹ 0.99 Billion ₹ 1.72 Billion ₹ 5.75 Billion
₹ 11.45 Billion ₹ 15.31 Billion ₹ 62.63 Billion
₹ 92.58 Billion ₹ 77.47 Billion Not disclosed
₹ 3.48 Billion ₹ 9.40 Billion ₹ 8.67 Billion
₹ 3.10 Billion ₹ 4.25 Billion ₹ 5.09 Billion
₹ 23.29 Billion ₹ 25.13 Billion ₹ 27.70 Billion
Not disclosed ₹ 67.24 million ₹ 369.86 Million
₹ 5.01 Billion ₹ 6.08 Billion ₹ 27.85 Billion
₹ 5.8 Billion ₹ 7.3 Billion ₹ 9.28 Billion
₹ 55.54 Billion ₹ 70.99 Billion ₹ 82.30 Billion
N/A N/A Not disclosed
₹ 336 Million ₹ 1.52 Billion ₹ 1.46 Billion
₹ 2 Billion ₹ 2.4 Billion ₹ 2 Billion
₹ 2.37 Billion ₹ 4.94 Billion ₹ 2.41 Billion
₹ 14.60 Billion ₹ 18.47 Billion ₹ 23.39 Billion
Entity acquired/ incorporated
during the year
Not applicable Not applicable
₹ 2.35 Billion ₹ 2.37 Billion ₹ 2.46 Billion
₹ 5.19 Billion ₹ 6.66 Billion ₹ 5.48 Billion
₹ 5.27 Billion ₹ 7.98 Billion ₹ 6.81 Billion

Entity acquired/ incorporated

Not applicable Not applicable during the year
₹ 530.57 Million ₹ 537.39 Million ₹ 398.54 Million
₹ 1.40 Billion ₹ 1.69 Billion ₹ 1.97 Billion

₹ 6.09 Billion ₹ 5.53 Billion ₹ 5 Billion

₹ 18.17 Billion ₹ 15.07 Billion ₹ 16.44 Billion
₹ 63.13 Million ₹ 85.67 Million ₹ 112.94 Million
₹ 444.95 Million ₹ 505.08 Million ₹ 406.19 Million
₹ 2.12 Billion ₹ 2.79 Billion ₹ 2.89 Billion

Not disclosed ₹ 5.92 Billion ₹ 5.41 Billion

Not disclosed Not disclosed Not disclosed
₹ 7.37 Billion ₹ 8.76 Billion ₹ 9.89 Billion

₹ 1.17 Billion ₹ 1.41 Billion ₹ 1.05 Billion

Not disclosed Not disclosed Not disclosed
 Total Revenue (Global) (₹/USD)
FY 2022 FY 2023 FY 2024
₹ 214.4 Billion ₹ 245.9 Billion ₹ 279.2 Billion
₹ 2784.6 Billion ₹ 3459.7 Billion ₹ 4379.3 Billion
₹ 386.54 Billion ₹ 438.85 Billion ₹ 484.97 Billion
₹ 217.64 Billion ₹ 227.53 Billion ₹ 257.74 Billion
₹ 875.4 Billion ₹ 1220 Billion ₹ 1410 Billion
₹ 1565.21 Billion ₹ 1833.41 Billion ₹ 2211.13 Billion
₹ 2.27 Billion ₹ 3.83 Billion ₹ 4 Billion
₹ 223 Billion ₹ 274.2 Billion ₹ 345.1 Billion
₹ 7887.4 Billion ₹ 9748.7 Billion ₹ 10,001.2 Billion
₹ 32.5 Billion ₹ 27.8 Billion ₹ 28.9 Billion
₹ 106.6 Billion ₹ 130.9 Billion ₹ 157.6 Billion
₹ 141.3 Billion ₹ 167.4 Billion ₹ 166.6 Billion
₹ 108.9 Billion ₹ 115.2 Billion ₹ 124.4 Billion

₹ 1463.7 Billion ₹ 1659.6 Billion ₹ 1752.88 Billion

₹ 2433.6 Billion ₹ 2291.7 Billion

₹ 131.27 Billion ₹ 146.62 Billion ₹ 133.68 Billion

₹ 58.7 Billion ₹ 46.9 Billion ₹ 39.25 Billion

₹ 629.3 Billion ₹ 778.8 Billion ₹ 977.8 Billion

₹ 66.24 Billion ₹ 76.52 Billion ₹ 63.07 Billion

₹ 16.9 Billion ₹ 20.53 Billion ₹ 14.39 Billion

₹ 1950.5 Billion ₹ 2232.2 Billion ₹ 2159.2 Billion
₹ 1.31 Billion ₹ 1.31 Billion ₹ 1.31 Billion
₹ 164 Billion ₹ 166.42 Billion ₹ 200.11 Billion
₹ 47.3 Billion ₹ 57.5 Billion ₹ 61.5 Billion
100- 500 Crore rs 100- 500 Crore rs 100- 500 Crore rs
₹ 4.31 Billion ₹ 3.87 Billion ₹ 3.83 Billion
₹ 31.84 Billion ₹ 26.78 Billion ₹ 28.41 Billion
₹ 462.1 Billion ₹ 535.8 Billion ₹ 430.98 Billion
₹ 1.9 Billion ₹ 2 Billion ₹ 2.5 Billion
₹ 1.2 Billion ₹ 1.55 Billion ₹ 1.57 Billion
₹ 99.21 Billion ₹ 118 Billion ₹ 123.8 Billion
₹ 65.6 Billion ₹ 70.8 Billion ₹ 81.71 Billion
₹ 4.36 Billion ₹ 5.46 Billion ₹ 6.3 Billion
₹ 5.8 Billion ₹ 6.98 Billion ₹ 8.94 Billion
₹ 234.56 Billion ₹ 248.27 Billion ₹ 290.27 Billion
₹ 25.25 Billion ₹ 30.41 Billion ₹ 32.18 Billion
₹ 45.02 Billion ₹ 41.93 Billion ₹ 37.81 Billion
₹ 65.2 Billion ₹ 59.47 Billion ₹ 64.97 Billion
 ₹ 30.7 Billion ₹ 36.88 Billion ₹ 40.51 Billion
₹ 123.05 Billion ₹ 115.83 Billion ₹ 118.13 Billion
₹ 85.08 Billion ₹ 96.28 Billion ₹ 107.28 Billion
₹ 124.23 Billion ₹ 137.83 Billion ₹ 152.06 Billion
₹ 22.7 Billion ₹ 23.17 Billion ₹ 24.78 Billion
₹ 4.97 Billion ₹ 15 Billion ₹ 15 Billion
₹ 14.9 Billion ₹ 18.5 Billion ₹ 21.78 Billion
₹ 0.895 Billion ₹ 1.41 Billion ₹ 1.51 Billion
₹ 15.5 Billion ₹ 18.5 Billion ₹ 25.15 Billion
₹ 61.28 Billion ₹ 80.90 Billion ₹ 93.23 Billion
₹ 144.7 Billion ₹ 144.9 Billion ₹ 133.9 Billion
₹ 50.83 Billion ₹ 55.42 Billion ₹ 47.84 Billion
₹ 16.76 Billion ₹ 21.57 Billion ₹ 19.39 Billion
₹ 68.45 Billion ₹ 80.20 Billion ₹ 76.82 Billion
₹ 137.42 Billion ₹ 172.82 Billion ₹ 199.14 Billion
₹ 82.89 Billion ₹ 87.49 Billion ₹ 103.35 Billion
₹ 65.05 Billion ₹ 97.58 Billion ₹ 173.40 Billion
₹ 210 Billion ₹ 181 Billion Not disclosed
₹ 209 Billion ₹ 245.68 Billion ₹ 253.78 Billion
₹ 21.65 Billion ₹ 25.39 Billion ₹ 27.56 Billion
₹ 106.34 Billion ₹ 115.99 Billion ₹ 126.67 Billion
₹ 28.54 Billion ₹ 67.50 Billion ₹ 113.97 Billion
₹ 83.96 Billion ₹ 115.50 Billion ₹ 156.21 Billion
₹ 58.55 Billion ₹ 59.68 Billion ₹ 66.58 Billion
₹ 152.65 Billion ₹ 172.37 Billion ₹ 195.5 Billion
₹ 138.89 Billion ₹ 168.68 Billion ₹ 185.50 Billion
₹ 20.43 Billion ₹ 28.11 Billion ₹ 41.26 Billion
₹ 87.33 Billion ₹ 101.48 Billion ₹ 98.18 Billion
₹ 102.97 Billion ₹ 144.42 Billion ₹ 165.35 Billion
₹ 37.64 Billion ₹ 45.11 Billion ₹ 45.06 Billion

₹ 38.34 Billion ₹ 32.76 Billion ₹ 49.42 Billion

₹ 89.91 Billion ₹ 79.74 Billion ₹ 80.02 Billion
₹ 36.85 Billion ₹ 44.45 Billion ₹ 37.94 Billion
₹ 45.51 Billion ₹ 66.12 Billion ₹ 61.95 Billion

₹ 10.66 Billion ₹ 16.01 Billion ₹ 15.05 Billion

₹ 24.94 Billion ₹ 19.40 Billion ₹ 15.39 Billion
₹ 21.30 Billion ₹ 26.75 Billion ₹ 31.84 Billion

₹ 28.42 Billion ₹ 30.11 Billion ₹ 36.01 Billion

₹ 53.06 Billion ₹ 56.53 Billion ₹ 62.29 Billion
₹ 9.53 Billion ₹ 12 Billion ₹ 15.71Billion
₹ 328.96 Billion ₹ 460.10 Billion ₹ 462.82 Billion
₹ 12.75 Billion ₹ 13.99 Billion ₹ 16.58 Billion

₹ 12.31 Billion ₹ 13.66 Billion ₹ 11.39 Billion

Not disclosed Not disclosed Not disclosed
₹ 34.45 Billion ₹ 37.36 Billion ₹ 39.76 Billion

₹ 9.8 Billion ₹ 11.71 Billion ₹ 11.2 Billion

Not disclosed Not disclosed $ 1.5 Billion

₹ 123.82 Billion ₹ 145.92 Billion ₹ 160 Billion

 No. of Employees in US
FY 2022 FY 2023 FY 2024
NA NA NA
735 735 735
1500 1500 1500
800 800 800
8600 8600 8600
Not Disclosed Not Disclosed Not Disclosed
Not Disclosed Not Disclosed Not Disclosed
15000 Estimated 15000 Estimated 15000 Estimated
51-200 51-200 51-200
142 144 150
84 84 84
Not Disclosed Not Disclosed Not Disclosed
Not Disclosed Not Disclosed Not Disclosed

800 800 800

51-200 51-200 51-200

105 105 105

13000 13000 13000

Not disclosed Not disclosed Not disclosed
Not Disclosed Not Disclosed Not Disclosed
Not disclosed Not disclosed Not disclosed
Not disclosed Not disclosed Not disclosed
11 to 50 11 to 50 11 to 50
35 to 50 35 to 50 35 to 50
201 to 500 201 to 500 201 to 500
Not disclosed Not disclosed Not disclosed
Not disclosed Not disclosed Not disclosed
Not disclosed Not disclosed Not disclosed
Not disclosed Not disclosed Not disclosed
Not disclosed Not disclosed Not disclosed
Not disclosed Not disclosed Not disclosed
959 1093 1283
500 to 1000 500 to 1000 500 to 1000
Not disclosed Not disclosed Not disclosed
201 to 500 201 to 500 201 to 500
Not disclosed Not disclosed Not disclosed
246 246 246
11 to 50 11 to 50 11 to 50
51 to 200 51 to 200 51 to 200
Not disclosed Not disclosed Not disclosed
Not disclosed Not disclosed Not disclosed
Not disclosed Not disclosed Not disclosed
Not disclosed Not disclosed Not disclosed
Not disclosed Not disclosed Not disclosed

N/A N/A N/A

2000 2000 2000

Not disclosed Not disclosed Not disclosed
Not disclosed Not disclosed Not disclosed
Not disclosed Not disclosed Not disclosed
Not disclosed Not disclosed Not disclosed
Not disclosed Not disclosed Not disclosed
Not Disclosed Not Disclosed Not Disclosed
Not disclosed Not disclosed Not disclosed

501-2000 501-2000 501-2000

Not disclosed Not disclosed Not disclosed

Not disclosed Not disclosed Not disclosed

Not disclosed Not disclosed Not disclosed

Not disclosed Not disclosed Not disclosed

Not disclosed Not disclosed Not disclosed

Not applicable Not applicable Not applicable

Not disclosed Not disclosed Not disclosed

Not disclosed Not disclosed Not disclosed
Not disclosed Not disclosed Not disclosed
300 300 300

Not disclosed Not disclosed Not disclosed

Not disclosed Not disclosed Not disclosed
 Total Global Employees
FY 2022 FY 2023 FY 2024
24,795 24,832 26,346
73,608 81,811 91,496
38,000 41,000 43,000
22,000 25,000 27,000
260,000 260,000 260,000
50,267 55,202 59,344
10,000 10,000 10,000
180,000 185,000 187,000
236,334 342,982 347,362
2,962 2,740 2,386
4,394 4,079 3,778
18,000 19,000 21,000
5,144 5,319 5,367

13,483 12,856 13,301

72,551 116,700 121,869

6,910 7,194 7,384

1,740 2,008 2,780
5,825 4,360 5,399
47,456 67,419 93,971
2,650 2,700 534

1,250 1,300 1,429

35,869 76,843 71,000
501 to 1000 501 to 1000 501 to 1000
19,789 20,933 19,210
6,647 8,120 8,353
201-500 201-500 201-500
327 337 397
8,687 7,114 7,126
13,054 13,000 12,000
201-500 201-500 201-500
235 231 227
7,622 7,310 7,914
6,000 6,295 6,719
755 800 831
34 34 57
25,000 34,000 37,000
1,512 1,258 2,172
2,125 2,395 2,459
1,592 5,706 5,969
 2,647 2,850 3,065
15,415 15,556 14,989
12,703 13,247 15,718
2,932 3,040 9,010
2,500 2,500 2,500
7,000 7,000 7,000
890 852 1,141
201 to 500 201 to 500 201 to 500
1,900 1,900 1,900
3,758 3,767 4,127
5,520 5,190 4,874
3,041 3,188 3,255
1,009 1,097 1,300
1,601 1,694 1,720
9,114 7,779 6,450
Not disclosed 22,000 23,279
26,000 26,000 30,000
2,640 2,508 Not disclosed
19,112 18,850 17,985
2,521 2,574 2,520
16,500 19,500 20,000
Not disclosed 7,814 9,300
15,000 16,500 16,315
10,584 10,584 10,584
23,743 23,026 26,240
5,970 6,822 6,712
4,760 4,491 4,800
3,229 3,472 3,590
4,636 5,002 5,249
5,427 5,873 6,525

Not disclosed Not disclosed Not disclosed

16,500 16,950 17,500
1,546 1,668 1,762
4000 6400 6200

1,491 1,532 3,282

1,952 1,994 1,720
3,555 4,064 4,674

5,000 5,000 6,000

12,216 14,593 14,800
1,521 1,573 1,600
5,555 6,015 6,191
 1,174 1,275 1,312

Not disclosed 3,289 2,902

Not disclosed Not disclosed Not disclosed
2,700 2,700 2,700

1001 to 5000 1001 to 5000 1001 to 5000

Not disclosed Not disclosed Not disclosed

5,100 5,200 5,100

Technology/Patents/Key Assets Acquired in US
Yes / No
Yes
Yes
Yes
Yes
Yes
Yes
No
Yes
Yes
Yes
Yes
Yes
Yes

Not clear

Yes
Yes

Yes
no
Yes
Yes

No
Yes
 Yes
Yes
Yes
Yes
Yes
No
Yes
Yes
Yes

No
Yes
no

Not clear
Yes

Yes
Yes

Yes

No

yes
Yes
Yes
Not disclosed
Yes

Yes
Not disclosed
Technology Transfer Back to India Earnings before Taxes (US Opera
Yes / No FY 2022
Yes NA
Yes Not Disclosed
Yes Not Disclosed
Yes Not Disclosed
Yes Not Disclosed
Yes Not Disclosed
No Not Disclosed
Yes Not Disclosed
Yes Not Disclosed
Yes Not Disclosed
Yes Not Disclosed
Yes Not Disclosed
No Not dislosed

Not clear Not dislosed

Yes ₹ 1.48 Billion

Yes Not disclosed
Not disclosed
Not disclosed

Yes ₹ 152.9 Billion

no Not Disclosed
Yes Not Disclosed
Yes Not disclosed
Not disclosed
Not disclosed
Not disclosed
Not disclosed
Not disclosed
Not disclosed
Not disclosed
Not disclosed
₹ 69.3 Million
Not disclosed
Not disclosed
Not disclosed
No Not disclosed
Yes Not disclosed
Yes Not disclosed
Yes ₹ 0.29 Billion
Yes Not disclosed
Yes Not disclosed
Yes Not disclosed
No Not disclosed
Yes ₹ 2.8 Billion
Yes Not disclosed
Yes Not disclosed
₹ 497 Million

₹ 113.7 Million
N/A
₹ 0.065 Million
No Not Disclosed
Not disclosed
No ₹ 1.12 Billion
₹ 16.06 Billion
₹ (-)196.71 Million
NIL ₹ 148 Million
₹ (-)110 Million
Not disclosed
Yes ₹ 325 Million
Yes Not disclosed
₹ (-)7.85 Billion
N/A
₹ (-)35.53 Million
₹ 81 Million
No ₹ 479 Million
₹ 433 Million

Not applicable
₹ 270 Million
₹ 976 Million
₹ 318 Million

Not applicable
₹ 21.92 Million
₹ 317.2 Million

₹ 529 Million
₹ 540 Million
₹ 3 Million
₹ 384 Million
 ₹ 47.32 Million

Not disclosed
Not disclosed Not disclosed
Yes ₹ 529 Million

Yes Not disclosed

Not disclosed Not disclosed
arnings before Taxes (US Operations) - Total Taxes Paid (US Op
FY 2023 FY 2024 FY 2022
60,485 72,010 NA
Not Disclosed Not Disclosed Not Disclosed
Not Disclosed Not Disclosed Not Disclosed
Not Disclosed Not Disclosed Not Disclosed
Not Disclosed Not Disclosed Not Disclosed
Not Disclosed Not Disclosed Not Disclosed
Not Disclosed Not Disclosed Not Disclosed
Not Disclosed Not Disclosed Not Disclosed
Not Disclosed Not Disclosed Not Disclosed
Not Disclosed Not Disclosed Not Disclosed
Not Disclosed Not Disclosed Not Disclosed
Not Disclosed Not Disclosed Not Disclosed
Not dislosed Not dislosed Not dislosed

Not dislosed Not dislosed ₹ 2.65 Billion

₹ 1.53 Billion ₹ 1.34 Billion

₹ 0.71 Billion ₹ 0.34 Billion ₹ 0.34 Billion

Not disclosed Not disclosed Not disclosed
Not disclosed Not disclosed Not disclosed
Not disclosed Not disclosed Not disclosed

₹ 145.3 Billion ₹ 155.7 Billion Not Disclosed

Not Disclosed Not Disclosed Not Disclosed
Not Disclosed Not Disclosed Not disclosed
Not disclosed Not disclosed Not disclosed
Not disclosed Not disclosed Not disclosed
Not disclosed Not disclosed Not disclosed
Not disclosed Not disclosed Not disclosed
Not disclosed Not disclosed Not disclosed
Not disclosed Not disclosed Not disclosed
Not disclosed Not disclosed Not disclosed
Not disclosed Not disclosed Not disclosed
Not disclosed Not disclosed Not disclosed
₹ 71.3 Million ₹ 71.5 Million Not disclosed
Not disclosed Not disclosed Not disclosed
Not disclosed Not disclosed Not disclosed
Not disclosed Not disclosed Not disclosed
Not disclosed Not disclosed Not disclosed
Not disclosed Not disclosed Not disclosed
 Not disclosed Not disclosed Not disclosed
- ₹ 1.2 Billion - ₹ 28.7 Billion ₹ 0.039 Billion
Not disclosed Not disclosed Not disclosed
Not disclosed Not disclosed Not disclosed
Not disclosed Not disclosed Not disclosed
Not disclosed Not disclosed Not disclosed
₹ 4.1 Billion ₹ 4.8 Billion Not disclosed
Not disclosed Not disclosed Not disclosed
Not disclosed Not disclosed Not disclosed
₹ 143 Million ₹ 129 Million ₹ 130 Million

₹ 130.3 Million ₹ 71.5 Million ₹ 33.5 Million

N/A N/A N/A
₹ 0.050 Million ₹ 0.065 Million ₹ 0.031 Million
Not Disclosed Not Disclosed Not Disclosed
₹ (-)498 Million ₹ 766 Million Not disclosed
₹ (-)662.7 Million ₹ 6.41 Billion ₹ 278.58 Million
₹ 2.23 Billion Not disclosed ₹ 2.26 Billion
₹ 202.19 Million ₹ (-)260.72 Million ₹ 0.27 Million
₹ 346 Million ₹ 729 Million ₹ 37 Million
₹ (-)82.9 Million ₹ 684.3 Million ₹ 0 Million
₹ 6.47 Million ₹ (-)42.44 Million Not disclosed
₹ 92 Million ₹ 1.18 Billion ₹ 97 Million
Not disclosed Not disclosed Not disclosed
₹ (-)7.64 Billion ₹ (-)2.38 Billion ₹ 635.24 Million
N/A Not Disclosed N/A
₹ (-)18.31 Million ₹ (-)180 Million ₹ 0.34 Million
₹ 159 Million ₹ 13.31 Million ₹ 7.98 Million
₹ 786 Million ₹ 534 Million ₹ 1.5 Million
₹ 274 Million ₹ 522 Million ₹ 121 Million
Entity acquired/
incorporated during the
year
Not applicable Not applicable
₹ 201 Million ₹ 160 Million ₹ 60 Million
₹ 949 Million ₹ 566 Million ₹ 202 Million
₹ 454 Million ₹ 306 Million ₹ 68.3 Million
Entity acquired/
incorporated during the
Not applicable year Not applicable
₹ 20.50 Million ₹ (-)71 Million ₹ 4.8 Million
₹ 369 Million ₹ 363.3 Million ₹ 82.06 Million

₹ 172 Million ₹ 116 Million ₹ 99.74 Million

₹ 393 Million ₹ 700 Million ₹ 135.90 Million
₹ 4.07 Million ₹ 5.44 Million ₹ 0.716 Million
₹ 120.08 Million ₹ 328 Million ₹ 66.74 Million
₹ 281 Million ₹ 247.18 Million ₹ 11.31 Million

₹ 942 Million ₹ 630 Million Not disclosed

Not disclosed Not disclosed Not disclosed
₹ 379 Million ₹ 530 Million Not disclosed

Not disclosed Not disclosed Not disclosed

Not disclosed Not disclosed Not disclosed
Taxes Paid (US Operations) - Total
FY 2023 FY 2024
45,073 55,779
Not Disclosed Not Disclosed
Not Disclosed Not Disclosed
Not Disclosed Not Disclosed
Not Disclosed Not Disclosed
Not Disclosed Not Disclosed
Not Disclosed Not Disclosed
Not Disclosed Not Disclosed
Not Disclosed Not Disclosed
Not Disclosed Not Disclosed
Not Disclosed Not Disclosed
Not Disclosed Not Disclosed
Not dislosed Not dislosed

₹ 1.27 Billion Not dislosed

₹ 0.5 Billion ₹ 0.2 Billion

₹ 0.24 Billion ₹ 0.1 Billion

Not disclosed Not disclosed
Not disclosed Not disclosed
Not disclosed Not disclosed

Not Disclosed Not Disclosed

Not Disclosed Not Disclosed
Not disclosed Not disclosed
Not disclosed Not disclosed
Not disclosed Not disclosed
Not disclosed Not disclosed
Not disclosed Not disclosed
Not disclosed Not disclosed
Not disclosed Not disclosed
Not disclosed Not disclosed
Not disclosed Not disclosed
Not disclosed Not disclosed
Not disclosed Not disclosed
Not disclosed Not disclosed
Not disclosed Not disclosed
Not disclosed Not disclosed
Not disclosed Not disclosed
Not disclosed Not disclosed
 Not disclosed Not disclosed
- ₹ 0.074 Billion - ₹ 0.731 Billion
Not disclosed Not disclosed
Not disclosed Not disclosed
Not disclosed Not disclosed
Not disclosed Not disclosed
Not disclosed Not disclosed
Not disclosed Not disclosed
Not disclosed Not disclosed
₹ 32 Million ₹ 30.7 Million

₹ 33.4 Million ₹ 17.1 Million

N/A N/A
₹ 0.27 Million ₹ 0.032 Million
Not Disclosed Not Disclosed
₹ 63.33 Million ₹ 58.28 Million
₹ (137.30) Million ₹ 1.45 Billion
₹ 582 Million Not disclosed
₹ (298.95) Million ₹ 4.97 Million
₹ 80 Million ₹ 143 Million
₹ 73.4 Million ₹ 27.7 Million
₹ 1.36 Million ₹ 4.48 Million
₹ 29 Million ₹ 298 Million
Not disclosed Not disclosed
₹ 723.12 Million ₹ 602.29 Million
N/A Not Disclosed
₹ 0.07 Million ₹ 0.09 Million
₹ 9.86 Million
₹ 105.4 Million ₹ 70.8 Million
₹ 86 Million ₹ 266 Million

Not applicable Entity acquired/ incorporated during the year

₹ 4.5 Million ₹ 20 Million
₹ 159 Million ₹ 95 Million
₹ 99.3 Million ₹ 65.9 Million

Not applicable Entity acquired/ incorporated during the year

₹ 4.8 Million ₹ 0 Million
₹ 86.24 Million ₹ 92.54 Million

₹ (32.4) Million ₹ 12.65 Million

₹ 99.50 Million ₹ 186.30 Million
₹ 0.978 Million ₹ 1.27 Million
₹ 77.09 Million ₹ 64.03 Million
₹ 24.40 Million ₹ 44.90 Million

₹ 162 Million ₹ 81.26 Million

Not disclosed Not disclosed
Not disclosed Not disclosed

Not disclosed Not disclosed

Not disclosed Not disclosed
S.NO NAME OF THE COMPANY
1 Carborundum Universal Ltd
29 Cadila Pharmaceuticals Ltd.
31 IFGL Refractories Ltd.
34 Jaipur Living Inc
38 Uniparts India Limited
Siddhi Integrated Manufacturing
41 Services, Inc
51 Essel Propack
55 The Hi-Tech Gears
Sanmar Engineering Technologies
60 Limited
NAME OF THE US SUBSIDIARY
Cumi America
Modavar Pharmaceuticals LLC/CPL Inc/CPL Biologicals US LLC
Mono Ceramics Inc/EI Ceramics LLC/IFGL Inc
Jaipur Living Inc
Uniparts USA Limited/Uniparts Olsen Inc

Siddhi Integrated Manufacturing Services, Inc

Essel Propack, LLC
Teutech

Matrix Metals LLC

Does not meet criteria

Mentioned in companies list
Meets criteria and is not on the list
INDUSTRY/ SECTOR Tracked
Engineering Yet to Track
Pharmaceutical Yet to Track
Refractories Yet to Track
Textiles Yet to Track
Engineering Yet to Track

Manufacturing Yet to Track

Packaging Yet to Track
Automotive Yet to Track

Engineering Yet to Track

25
26
9
No. Company Name Email address
1 Dr. Reddy's Laboratories Limited [email protected]
2 Tata Motors [email protected]
3 Sun Pharmaceutical [email protected]
4 Cipla [email protected]
5 Mahindra & Mahindra [email protected]
6 Larsen & Toubro (L&T) [email protected]
7 Aditya Birla Group [email protected]
8 Reliance Industries [email protected]
9 Wockhardt [email protected]
10 Bharat Forge
11 Godrej Group [email protected]
12 Dabur [email protected]
13 JSW Steel
14 Tata Steel
15 Uflex
16 Jindal Poly Films
17 Samvardhana Motherson Group
18 Polyplex
19 Novelis : Hindalco
20 Surya Carpet
21 Lupin Pharmaceuticals
22 Jain Irrigation Systems Ltd
23 Sarla Performance Fibers
24 Himatsingka Seide
25 United Phosphorus
26 Woodfield Systems
27 Indian Toners
28 Pidilite
29 Piramal Healthcare
30 Setco Automotive
31 Epsilon Advanced Materials
32 Aurobindo Pharma Limited
33 Elgi Equipment Limited
34 Suzlon Energy
35 Strides Arcolab Ltd
36 Glenmark Pharmaceuticals
37 Torrent Pharmaceuticals
38 TATA consumer products
39 INDO-MIM
40 Essar Group
41 Marksans Pharma
42 Enzene Biosciences
43 Vikram Solar
44 Thermax Limited
45 NALCO (National Aluminium Company)
46 Atul Limited
47 Vinati Organics
48 Deepak Nitrite
49 KEC International Ltd
50 Mankind Pharmaceuticals
51 Welspun Corp
52 RAIN Industries Limited
53 Apollo Tyres
54 Kirloskar Brothers Limited
55 Alkem Laboratories
56 Waaree Energies
57 Biocon
58 Emcure Pharmaceuticals
59 Zydus
60 Havells India
61 Natco Pharmaceuticals
62 BKT Tires
63 Eicher Motors
64 Granules Pharmaceuticals

65 Sterlite
66 Divi's Laborateries
67 Galaxy Surfactants
68 Gujarat Fluorochemicals

69 Anupam Rasayan India

70 Meghmani Organics Ltd
71 Sona BLW Precision Forgings Ltd.

72 Indo Count Industries Ltd.

73 Alembic Pharmaceuticals Ltd.
74 Neuland Laboratories Ltd.
75 Carborundum Universal Ltd

76 IFGL Refractories Ltd.

77 Jaipur Living Inc
78 Uniparts India Limited
79 Siddhi Integrated Manufacturing Services
80 Essel Propack
81 The Hi-Tech Gears
82 Sanmar Group
83 Cadila Pharmaceuticals Ltd.
84 Indian Oil Corporation
85 Exide Industries
86 UNO Minda Group
87 Gland Pharmaceuticals
88 GreenKo Energy Holdings
Name Designation
K. Kulbhushan Global Head and Vice President – Operations Strategy and Excellence and D
Balaje Rajan Chief Strategy Officer
Meeta Chatterjee Chief Strategy Officer
Satyen Manikani Head -Product Portfolio and Strategy
Rahul Sharan Group Investments & Strategy
Dola Mahapatra Operations and Corporate Strategy
Rakesh Paliwal Head Strategy & Business Development
Sandeep Dutta Vice President – HR, Strategy & Business Transformation
Ankeet Doshi Vice President & Head of Corporate Strategy

Navroze Godrej Executive Director of Godrej & Boyce

Karan Arora Head of Corporate Affairs
Arun Sitaram Maheshw
Director- corporate strategy
Shankar Marar Director of Strategic Capex

Sanjeev Yadav Director of new product development

Dr. Fabrice Egros President of Corporate Development

Prabhakar Jain Chief Strategy and Business Development Officer

Dr. Premendra Chief Strategy Officer

Himanshu Mody Chief Financial Officer
 Strategy and Excellence and Digital. ​

ransformation

pment Officer
LIST OF COMPANIES

Dr Reddy

Investment

Tata Motors

Investment

Sun Pharma

Cipla

Mahindra and Mahindra

JSW

L&T
Taj Hotels

Aditya Birla Group

To Invest

Reliance Industries

Investment

Wockhardt

Investment

Bharat Forge

Godrej Group

Dabur
Investment

Deepak Nitrite

Vinati Organics

Atul Limited

JSW
 Investment

Tata steel

Thermax Limited

Eicher Motors

Uflex

Jindal Poly Film

Investment

BKT Tires

Samvardhana Motherson Group

Polyplex

Lupin

Jain Irrigation

Sarla Performance
fibres
Natco Pharmaceuticals

Suzlon Energy

Havells India

Colourtex

Strides Pharma

Glenmark pharma

Torrent Pharma

Investment

Tata Consumer
Products

Indo MIM
Essar Group

Enzeme Biosciences

Marksans Pharma

Surya Carpets

Vikram Solar

Hindalco

Zydus

Mankind Pharmaceutical

Biocon

Waaree Energies

Alkem Laboratories

Kirloskar Brothers Limite

Apollo Tyres

RAIN Industries Limited

Welspun Corp

Sterlite

Investment

Granules Pharmaceutical

Divi's Laborateries

Galaxy Surfactants

Gujarat Fluorochemicals

Anupam Rasayan India

Investment

Meghmani Organics Ltd

Sona BLW Precision Forgi

Vardhman Textiles Ltd

Indo Count Industries Ltd

Alembic Pharmaceuticals

Neuland Laboratories Ltd

Carborundum Universal
Ltd

IFGL Refractories Ltd.

Uniparts India Limited

Essel

Hi tech gears
https://edpnc.com/expand-to-the-us/from-india/
https://indiainatlanta.gov.in/public_files/assets/pdf/Compendium_aug_29_2024.pdf
http://test.pharmabiz.com/chronicle%20specials/top-indian-cos-strengthening-base-in-us-europe-3131
https://businessintexas.com/foreign-investment/india/
https://www.choosenj.com/about-us/njic/
https://www.roi-nj.com/2018/06/21/industry/meet-the-man-who-has-brought-18-companies-to-n-j-from
https://www.indiaglobalbusiness.com/igb-archive/matching-up-kentucky-businesses-with-india-india-g
https://www.ft.com/content/78f52ebd-13ba-4a38-843a-c156f2415e8b
https://www.saurenergy.com/solar-energy-blog/5-indian-solar-firms-with-plans-to-make-in-usa

https://www.drreddys.com/cms/cms/sites/default/files/2024-07/Dr.%20Reddy%27s%20-%20Integrated
https://www.drreddys.com/cms/cms/sites/default/files/2023-07/Dr.%20Reddy%E2%80%99s%20Integr
https://www.drreddys.com/cms/cms/sites/default/files/2022-07/Annual_Report_FY2022.pdf
https://www.fiercepharma.com/pharma/dr-reddys-bolsters-us-generics-111-million-mayne-pharma-ass
https://www.drreddys.com/media/264190/drreddys-teva-deal.pdf

https://static-assets.tatamotors.com/Production/www-tatamotors-com-NEW/wp-content/uploads/2024/
https://www.tatamotors.com/wp-content/uploads/2023/12/AnnualReport202223.pdf
https://leadiq.com/c/tata-motors/5a1d958f2300005900844113/employee-directory
https://media.jaguarlandrover.com/node/4917

https://www.bajajbroking.in/blog/sun-pharmaceutical-industries#:~:text=1997%3A%20This%20year%
https://sunpharma.com/wp-content/uploads/2024/07/SPIL-Annual-Report-2023-24.pdf
https://sunpharma.com/wp-content/uploads/2023/07/SPIL-AR2022-23-Complete-Annual-Report.pdf

https://www.cipla.com/press-releases-statements/cipla-acquire-100-generic-businesses-us-550m-0#:~
https://www.cipla.com/sites/default/files/Annual%20Report%202023-24-%28Single%20page%29.pdf
https://www.cipla.com/sites/default/files/Annual-Report-FY-2022-23.pdf

https://www.business-standard.com/article/companies/mahindra-group-to-double-us-investment-by-20
https://www.mahindra.com/our-business-usa
https://www.zoominfo.com/c/mahindra-usa-inc/106677028
https://stockanalysis.com/quote/nse/M&M/employees/
https://www.mahindra.com/annual-report-FY2023/254/index.html
https://en.wikipedia.org/wiki/Mahindra_%26_Mahindra
https://rocketreach.co/mahindra-usa-inc-profile_b5dd3e3af42e5465

https://jswsteel.us/about-us/#:~:text=We%20strive%20to%20build%20on,Ohio%2C%20and%20Bayto
https://stockanalysis.com/quote/nse/JSWSTEEL/employees/
https://stockanalysis.com/quote/nse/JSWSTEEL/financials/
https://www.jswsteel.in/sites/default/files/assets/industry/steel/IR/JSW_Steel_Tax-Transparency-Report

https://www.ltts.com/press-release/Q4FY23-results#:~:text=During%20the%20quarter%2C%20LTTS%
https://www.larsentoubro.com/media/39831/iprebg-pressrelease-april-27-2009.pdf#:~:text=This%20c
https://investors.larsentoubro.com/upload/AnnualRep/FY2023AnnualRepLT%20Integrated%20Annual%

https://www.statista.com/statistics/1220259/taj-hotels-resorts-and-palaces-revenue/#:~:text=Taj%20

https://www.adityabirla.com/businesses/countries/us/
https://www.adityabirlacapital.com/-/media/ABCL/pdf/Financial-Reports/Annual-Reports-2023-24/2307
https://www.adityabirlacapital.com/-/media/ABCL/pdf/Financial-Reports/Annual-Report-2022-23/ABCL-A
https://www.adityabirla.com/businesses/countries/us/
https://www.business-standard.com/companies/news/aditya-birla-group-to-invest-50-mn-in-manufactu

https://www.ril.com/ar2023-24/pdf/RIL_IAR_2024.pdf
https://rilstaticasset.akamaized.net/sites/default/files/2023-09/RIL-Integrated-Annual-Report-2022-23.p
https://stockanalysis.com/quote/vie/RLI/employees/
https://timesofindia.indiatimes.com/gadgets-news/reliance-industries-takes-majority-stake-in-us-based

https://stockanalysis.com/quote/nse/WOCKPHARMA/employees/
https://www.wockhardt.com/wp-content/uploads/2023/07/annual-report-2022-2023.pdf
https://www.wockhardt.com/wp-content/uploads/2024/06/annual-report-2023-2024.pdf
https://www.reuters.com/article/business/healthcare-pharmaceuticals/wockhardt-buys-us-morton-grov

https://economictimes.indiatimes.com/markets/stocks/news/bharat-forge-stock-in-focus-after-co-appro
https://growjo.com/?query=bharat%20forge
https://patents.justia.com/assignee/bharat-forge-limited#:~:text=Abstract:%20The%20present%20in

https://www.godrejindustries.com/public/uploads/reports/2023-24/GIL_Annual_Report_2023-24.pdf
https://www.godrejindustries.com/public/uploads/reports/2022-23/GIL-Annual-Report-2023.pdf
https://economictimes.indiatimes.com/jobs/hr-policies-trends/godrej-industries-ramps-up-hiring-at-gro
https://www.godrejnorthamerica.com/know-us/godrej-north-america#:~:text=Our%20Corporate%20C
https://insights-greyb-com.webpkgcache.com/doc/-/s/insights.greyb.com/godrej-consumer-products-p
https://www.jonesday.com/en/practices/experience/2016/04/godrej-son-holdings-and-godrej-consume

https://www.dabur-usa.com/about-us
https://economictimes.indiatimes.com/industry/cons-products/fmcg/dabur-completes-acquisition-of-us

https://stockanalysis.com/quote/nse/DEEPAKNTR/employees/
Annual Financial Reports 2021-22, 2022-23, 2023-24
https://www.business-standard.com/markets/capital-market-news/vinati-organics-incorporates-subsidi
https://vinatiorganics.com/wp-content/uploads/2022/08/April-2021-to-March-2022.pdf
https://vinatiorganics.com/wp-content/uploads/2023/08/ANNUAL-REPORT-FOR-THE-FINANCIAL-YEAR-2
https://vinatiorganics.com/wp-content/uploads/2024/08/Vinati-Organics-Limited-AR-2024_C2C_16-08-2
https://www.atul.co.in/pdf/investors/information-for-stakeholders/integrated-reports/Atul-IR-2023-24.p
https://www.atul.co.in/pdf/investors/information-for-stakeholders/annual-reports/Atul-2022-23.pdf
https://www.atul.co.in/pdf/investors/information-for-stakeholders/annual-reports/Atul-2021-22.pdf

https://www.moneycontrol.com/financials/jswsteel/consolidated-profit-lossVI/jsw01#jsw01
https://www.jswsteel.in/jsw-steel-annual-report-2023-24/JSW-Steel-IR24.pdf
https://www.thehindu.com/business/jsw-steel-usa-to-invest-110-million-in-texas-facility/article6833165

https://www.tatasteel.com/media/21241/tata-steel-limited-ir-2024.pdf
https://www.tatasteel.com/media/18370/tata-steel-ir-2022-23.pdf

https://www.thermaxglobal.com/wp-content/uploads/2022/07/Thermax-Annual-Report-FY2022.pdf
https://www.thermaxglobal.com/wp-content/uploads/2022/07/Thermax-Annual-Report-FY2022.pdf
https://www.thermaxglobal.com/wp-content/uploads/2024/07/Thermax_43-Annual-Report.pdf
https://eicher.in/content/dam/eicher-motors/investor/financial-and-reports/annual-reports/Eicher-Moto
https://eicher.in/content/dam/eicher-motors/investor/financial-and-reports/annual-reports/Annual%20R
https://eicher.in/content/dam/eicher-motors/investor/financial-and-reports/annual-reports/Eicher%20M

https://www.uflexltd.com/pdf/financials/annual-reports/UFLEX-AR-2023-24.pdf
https://www.uflexltd.com/pdf/financials/annual-reports/UFLEX-AR-2022-23.pdf
https://www.linkedin.com/company/flex-films-usa-inc/about/
https://www.thehindubusinessline.com/companies/Uflex-to-invest-180-m-in-new-facility-in-US/article2

https://www.bseindia.com/xml-data/corpfiling/AttachHis/7046da14-d950-4b17-8096-eef27bc6d6d0.pd
https://www.bseindia.com/xml-data/corpfiling/AttachHis/%5C7e1369ed-2751-4431-b574-68c60c07fda
https://www.vccircle.com/jindal-poly-films-buy-global-bopp-business-exxonmobil-235m

https://www.bkt-tires.com/downloads/15081/12236/Annual_Report_2023-24.pdf
https://www.bkt-tires.com/downloads/14342/11843/BKT_AR_2023_with_notice.pdf
https://www.bkt-tires.com/downloads/9782/8449/Integrated%20Annual%20Report%202021-22.pdf

https://www.motherson.com/storage/annual-report/2023-24/SAMIL_AR_2023-24.pdf
https://www.motherson.com/storage/annual-report/2023-24/SAMIL_AR_2023-24.pdf

https://stockanalysis.com/quote/nse/POLYPLEX/employees/

https://stockanalysis.com/quote/bom/500257/employees/
https://stockanalysis.com/quote/bom/500257/financials/

https://stockanalysis.com/quote/bom/500219/financials/
https://stockanalysis.com/quote/bom/500219/employees/
https://www.jains.com/AGM/AnnualReport2022/JISL_Annual_Report_FY2021_22.html

https://www.sarlafibers.com/wp-content/uploads/2024/07/Sarla-Performance-Fibers-Limited-Annual-Re
https://stockanalysis.com/quote/bom/526885/employees/
https://www.moneycontrol.com/financials/sarlaperformancefibers/consolidated-profit-lossVI/spf01#spf
https://www.natcopharma.co.in/wp-content/uploads/2024/09/Natco-Pharma-AR-2023-24-final-file.pdf
https://www.natcopharma.co.in/wp-content/uploads/2023/09/Annual-Report-2022-23.pdf
https://www.natcopharma.co.in/wp-content/uploads/2022/09/NATCO-AR-2022.pdf

https://www.suzlon.com/NewPdf/Financial_Reports_&_Presentations/2023-24/Annual_Report_2023-202
https://stockanalysis.com/quote/bom/532667/employees/
https://www.suzlon.com/in-en/investor-relations/financial-reports-presentations

https://havells.com/media/wysiwyg/PDF/Financial/Annual-Reports/2021-2022/Integrated_Report.pdf
https://havells.com/media/wysiwyg/PDF/Financial/Annual-Reports/2022-2023/Integrated-Report.pdf
https://havells.com/media/wysiwyg/PDF/Financial/Annual-Reports/2023-2024/Integrated-Report.pdf

https://platform.tracxn.com/a/d/company/RYoVOGPPbpxzGXJRN_kTiZDeQdWSsceRON3W-roxztE/colou
https://tracxn.com/d/legal-entities/india/colourtex-industries-private-limited/__0q0eGlRkOcUlNI7TKMiY

https://stockanalysis.com/quote/bom/532531/financials/
https://strides.com/pharma-united-states.html
https://www.strides.com/pdf/financial%20results/annual_results/fy_2023_24/Consolidated_annual.pdf
https://www.cnbctv18.com/market/earnings/strides-pharma-400-million-guidelines-next-two-years-res
https://www.icra.in/Rating/GetRationalReportFilePdf/125312~Strides%20Pharma%20Science%20Limit

https://stockanalysis.com/quote/nse/GLENMARK/employees/
https://stockanalysis.com/quote/nse/GLENMARK/financials/
https://www.prnewswire.com/in/news-releases/glenmark-pharmaceuticals-ltd-reports-consolidated-rev
https://glenmark.b-cdn.net/gpl_pdfs/investors/reports_presentations/GPL_Annual_Report_2324a.pdf
https://glenmark.b-cdn.net/gpl_pdfs/investors/reports_presentations/Glenmark%20AR2022-23%20%28
https://www.business-standard.com/markets/capital-market-news/glenmark-pharma-climbs-after-turn
https://glenmark.b-cdn.net/gpl_pdfs/responsibility/TTR_FY24_V9.pdf
https://glenmark.b-cdn.net/gpl_pdfs/responsibility/Glenmark%20-%20TTR%20-%20FY%202022-23.pdf

https://stockanalysis.com/quote/bom/500420/financials/
https://stockanalysis.com/quote/bom/500420/employees/
https://www.torrentpharma.com/assets/Annual_Report_2023_24_Single_page_view_e83a64cdc8.pdf
https://www.torrentpharma.com/assets/Annual_Report_2022_23_Single_page_view_6ce9daddfa.pdf
https://www.torrentpharma.com/business-area/international-business/
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/torrent-pharma-b
https://www.pharmaceutical-technology.com/news/torrent-pharma-curatio/#:~:text=The%20latest%2

https://stockanalysis.com/quote/bom/500800/financials/
https://stockanalysis.com/quote/bom/500420/employees/
https://www.tataconsumer.com/sites/g/files/gfwrlq316/files/2023-05/INTEGRATED%20ANNUAL%20REP
https://www.statista.com/statistics/1112821/tata-consumer-products-revenue-share-by-geographic-se

https://www.indo-mim.com/wp-content/uploads/2024/09/Annual-Report-FY-2024.pdf
https://platform.tracxn.com/a/d/company/cvJkMGP5n4DLl7HvPPGxJmEe-XbZ5RWfSXd2F3QnBiM/indo-m
https://www.indo-mim.com/wp-content/uploads/2024/09/Annual-Report-FY-2024.pdf
https://www.indo-mim.com/metal-injection-molding-company-corporate-profile/

https://www.business-standard.com/companies/news/essar-group-to-invest-650-mn-more-in-us-steel-p
https://www.financialexpress.com/business/industry-essar-2-0-ruias-script-zero-debt-asset-light-busine
https://www.essar.com/inthenews/essar-oil-gas-exploration-production-eogepl-achieves-highest-fiscal-

https://www.alkemlabs.com/pdf/subsidiary-account/22-23/Enzene%20Biosciences%20Limited%20-%2
https://www.alkemlabs.com/pdf/subsidiary-account/20-21/Enzene-Biosciences-Limited-India.pdf

https://stockanalysis.com/quote/bom/524404/financials/
https://stockanalysis.com/quote/bom/524404/employees/
https://www.marksanspharma.com/pdf/annual-report/marksans-annual-report-2023-2024.pdf
https://www.marksanspharma.com/pdf/investor-presentation-august-2024.pdf

https://timesofindia.indiatimes.com/life-style/fashion/luxury/featured/from-threads-to-trends-surya-livi
https://platform.tracxn.com/a/d/legalentity/6408561eb0cc4d59ef3a09b2/Surya%20Carpet%20Private%

https://unlistedzone.com/vikram-solar-financial-performance-fy23-vs-fy24-a-comparative-analysis-of-r
https://www.vikramsolar.com/financial-performance/
https://www.vikramsolar.com/wp-content/uploads/2021/12/VSL%20FS%20FY%202020-21.pdf
https://www.vikramsolar.com/press-releases/vikram-solar-wins-393-9-mwp-module-supply-order-for-n

https://www.hindalco.com/upload/pdf/hindalco-annual-report-2023-24.pdf
https://stockanalysis.com/quote/bom/500440/employees/
https://www.hindalco.com/integrated-annual-report2022-23/pdf/Hindalco-Integrated-Annual-Report-20
https://stockanalysis.com/quote/bom/500440/financials/

https://www.zyduslife.com/public/pdf/financial/annual/Annual-Report%202021-2022.pdf
https://www.zyduslife.com/investor/admin/uploads/14/2/2022-2023.pdf
https://www.zyduslife.com/investor/admin/uploads/14/2/2023-2024_1.pdf

https://www.mankindpharma.com/wp-content/uploads/2024/12/mankind-pharma-limited-annual-repor
https://www.mankindpharma.com/wp-content/uploads/2024/12/mankind-ar-2023-24-1721652051.pdf

https://www.biocon.com/docs/Biocon_Annual_Report_2022.pdf
https://www.biocon.com/docs/Biocon_Integrated_Annual_Report_2023.pdf
https://www.biocon.com/docs/Biocon_Integrated_Annual_Report_2024.pdf

https://waaree.com/wp-content/uploads/2024/01/Waaree_Energies_Limited_Annual_Report_2022_202
https://waaree.com/wp-content/uploads/2024/09/Waaree-Energies_Annual-Report-2023-24-2.pdf

https://admin.alkemlabs.com/uploads/Annual_Report_2021_22_b19a81ca95.pdf
https://admin.alkemlabs.com/uploads/Alkem_Laboratories_AR_2022_23_C2_C_single_page_view_for_w
https://admin.alkemlabs.com/uploads/alkem_labs_ar_2023_24_C2_C_26_07_2024_high_res_1890c8a8e

https://www.kirloskarpumps.com/wp-content/uploads/2022/09/102AR.pdf
https://www.kirloskarpumps.com/wp-content/uploads/2023/07/KBL_Annual-Report-2023_Final_R1.pdf
https://www.kirloskarpumps.com/wp-content/uploads/2024/07/KBL-Annual-Report-23-24.pdf
https://corporate.apollotyres.com/content/dam/orbit/apollo-corporate/investors/financial-reporting/ann
https://corporate.apollotyres.com/content/dam/orbit/apollo-corporate/investors/financial-reporting/ann
https://corporate.apollotyres.com/content/dam/orbit/apollo-corporate/investors/financial-reporting/ann

https://www.rain-industries.com/assets/pdf/ril-48th-annual-report-2022.pdf
https://www.rain-industries.com/annual-report-2023/pdf/Rain-Industries-AR-2023.pdf

https://www.welspuncorp.com/uploads/investor_data/investorreport_Financial%20year%202021%20-%
https://www.welspuncorp.com/uploads/investor_data/investorreport_Financial%20year%202022%20-%
https://www.welspuncorp.com/uploads/investor_data/investorreport_Financial%20year%202022%20-%

https://www.sterlitepower.com/wp-content/uploads/2022/08/Sterlite-Power-Annual-Report-2021-22.pd
https://www.sterlitepower.com/wp-content/uploads/2023/09/Sterlite-Power-Annual-Report-2022-23.pd
https://www.sterlitepower.com/wp-content/uploads/2024/11/Sterlite-Power-Annual-Report-2023-24.pd
https://ipfonline.com/news/detail/industrynews/sterlite-invests-56-million-in-us-fiber-facility-targets-10

https://granulesindia.com/wp-content/uploads/2022/09/Granules-India-AR-2021-22.pdf
https://granulesindia.com/wp-content/uploads/pdf/Granules-AR-2022-23.pdf
https://granulesindia.com/wp-content/uploads/2024/07/GranulesIndia-limited-AR-2023-24.pdf

file:///C:/Users/maitr/Downloads/32nd-Annual-Report-2021-22_Divis-Lab.pdf
https://www.divislabs.com/wp-content/uploads/2023/08/Annual-Report-2022-23_Divis-Laboratories-Lim
https://www.divislabs.com/wp-content/uploads/2024/10/Annual-Report.pdf

https://www.galaxysurfactants.com/pdf/financial-performance/2021-22/annual/Annual_Report_2021-2
https://www.galaxysurfactants.com/pdf/financial-performance/2022-23/annual/Annual-Report-2022-23
https://www.galaxysurfactants.com/pdf/financial-performance/2023-24/annual/Annual-Report-2023-24

https://www.gfl.co.in/upload/pages/591aac25d2118d9b5d9a10b48a685415.pdf
https://www.gfl.co.in/upload/pages/c1c6dc1d169ff36db55f31335cb15e2f.pdf
https://www.gfl.co.in/upload/pages/GFCL-Integrated_Annual_Report_2023-24.pdf

https://anupamcms.tinglabs.in/uploads/Annual_Report_FY_2021_22_f86c8a742f.pdf
https://anupamcms.tinglabs.in/uploads/Anupam_Rasayan_AR_2023_486ecefdee.pdf
https://anupamcms.tinglabs.in/uploads/Annual_Report_2023_24_f5b94cef02.pdf
https://www.business-standard.com/markets/capital-market-news/anupam-rasayan-incorporates-subs

https://meghmani.com/wp-content/uploads/2022/06/mol-annual-report-2021-22.pdf
https://meghmani.com/wp-content/uploads/2023/06/Annual-Report-2022-23.pdf
https://meghmani.com/wp-content/uploads/2024/06/Annual-Report-2023-24.pdf

https://sonacomstar.com/files/documents/annual-report-document-RT3Qx9.pdf
https://sonacomstar.com/annual-report-22-23/pdf/sona-comstar-ar.pdf
https://sonacomstar.com/files/documents/annual-report-document-SasqXX.pdf

https://www.vardhman.com/Document/Report/Financials/Annual/Vardhman%20Textiles%20Ltd/Annua
https://www.vardhman.com/Document/Report/Financials/Annual/Vardhman%20Textiles%20Ltd/Annua
https://www.vardhman.com/Document/Report/Financials/Annual/Vardhman%20Textiles%20Ltd/Annua

https://www.indocount.com/images/investor/Annual_Report-for-2021-22.pdf
https://www.indocount.com/images/investor/Annual-Report-for-2022-23.pdf
https://www.indocount.com/images/investor/Annual-Report-For-2023-24.pdf

https://alembicpharmaceuticals.com/webfiles/pdf/Investor/annual-reports/2021-2022/Q1/Alembic-Phar
https://alembicpharmaceuticals.com/webfiles/pdf/Investor/annual-reports/2022-2023/Q2/Alembic-Inter
https://alembicpharmaceuticals.com/webfiles/pdf/Investor/annual-reports/2023-2024/Q1/Annual%20R

https://www.neulandlabs.com/sites/neulandlabs/files/neuland-labs/Investors/financials-and-reports/ann
https://www.neulandlabs.com/sites/neulandlabs/files/neuland-labs/Investors/Annual-Report-neuland-2
https://www.neulandlabs.com/sites/neulandlabs/files/neuland-labs/Investors/financials-and-reports/int

https://www.cumi-murugappa.com/wp-content/themes/CUMI/pdf/68th-Annual-Report.pdf
https://www.cumi-murugappa.com/wp-content/uploads/2023/07/CUMI-69th-Annual-Report-2023.pdf
https://www.cumi-murugappa.com/wp-content/uploads/2024/07/CUMI-AR-2024.pdf

https://ifglgroup.com/wp-content/uploads/2023/02/2021-2022.pdf
https://ifglgroup.com/wp-content/uploads/2023/08/IFGL-AR-_-0108023.pdf
https://ifglgroup.com/wp-content/uploads/2024/07/Annual_Report_2023_24.pdf

https://www.unipartsgroup.com/pdfs/Annual-Report_21-22n.pdf
https://www.unipartsgroup.com/pdfs/Uniparts-AR_FY22-23.pdf
https://www.unipartsgroup.com/pdfs/Annual_Report-Unipart_28-08-24_final-compressed2.pdf

https://www.eplglobal.com/wp-content/uploads/2024/08/SEOutcome-May282024sd-1.pdf
https://www.eplglobal.com/wp-content/uploads/2024/08/SEOutcome-May282024sd-1.pdf

https://www.thehitechgears.com/Content/pdf/AnnualReports2023-2024.pdf
https://www.thehitechgears.com/Content/pdf/AnnualReports2022-2023.pdf
se-in-us-europe-31318

companies-to-n-j-from-india/
ses-with-india-india-global-business

-make-in-usa

7s%20-%20Integrated%20Annual%20Report%202023-24.pdf
2%80%99s%20Integrated%20Annual%20Report%202022-23_0.pdf
Y2022.pdf
n-mayne-pharma-asset-deal#:~:text=Reddy's%20bolsters%20US%20generics%20business,to%20buy%20May

ontent/uploads/2024/05/tata-motor-IAR-2023-24.pdf

3A%20This%20year%2C%20Sun%20Pharma,enhancing%20Sun%20Pharma's%20product%20portfolio.

Annual-Report.pdf

nesses-us-550m-0#:~:text=Cipla%20to%20acquire%20100%25%20of,US%20for%20%24550M%20%7C%20Cip
le%20page%29.pdf

e-us-investment-by-2022-says-pawan-goenka-117071800334_1.html

%2C%20and%20Baytown%2C%20Texas.

Transparency-Report-FY-2023-24.pdf

uarter%2C%20LTTS%20won,share%20recommended%20by%20the%20Board
df#:~:text=This%20creates%20huge%20value%20for%20the%20organization,L&T%20technology.%20We%20
tegrated%20Annual%20Report%202023.pdf

ue/#:~:text=Taj%20Hotels%20revenue%20FY%202018%2D2022&text=In%20financial%20year%202022%2C%

eports-2023-24/230724_Annual-Report-for-2023-24.webp?extension=webp
eport-2022-23/ABCL-Annual-Report-FY-22-23.webp?extension=webp

t-50-mn-in-manufacturing-r-and-d-centre-in-texas-124062600337_1.html

nual-Report-2022-23.pdf

rity-stake-in-us-based-company-for-rs-2-5-billion-details/articleshow/94021589.cms

-buys-us-morton-grove-for-38-mln-idUSBOM95298/

n-focus-after-co-approves-64-50-mn-infusion-in-bfa/articleshow/116615689.cms?from=mdr

he%20present%20invention%20is%20directed%20to,carriers%20or%20integral%20planet%20carriers%20mad

port_2023-24.pdf
port-2023.pdf
amps-up-hiring-at-group-companies-to-push-growth/articleshow/112355460.cms?from=mdr
ur%20Corporate%20Centre%20of%20Excellence,brands%20that%20they%20are%20servicing.
consumer-products-patents/
-and-godrej-consumer-products-holding-mauritius-limited-obtain-financing-for-acquisition-of-strength-of-nature

etes-acquisition-of-us-based-namaste-group/articleshow/7210485.cms?from=mdr

s-incorporates-subsidiary-in-delaware-usa-125021800589_1.html

HE-FINANCIAL-YEAR-2022-2023.pdf
AR-2024_C2C_16-08-2024.pdf
rts/Atul-IR-2023-24.pdf
Atul-2022-23.pdf
Atul-2021-22.pdf
acility/article68331655.ece

eport-FY2022.pdf
eport-FY2022.pdf
al-Report.pdf
l-reports/Eicher-Motors-Integrated-Annual-Report-2023-24.pdf
l-reports/Annual%20Report%20Financial%20Year-2022-23.pdf
l-reports/Eicher%20Motors%20Integrated%20Annual%20Report%202021-22.pdf

facility-in-US/article20191308.ece#:~:text=Flexible%20packaging%20firm%20Uflex%20Ltd%20will%20be,prox

096-eef27bc6d6d0.pdf
31-b574-68c60c07fdaa.pdf

rt%202021-22.pdf

ers-Limited-Annual-Report-FY-23-24.pdf

rofit-lossVI/spf01#spf01
023-24-final-file.pdf

ual_Report_2023-20241.pdf

egrated_Report.pdf
egrated-Report.pdf
egrated-Report.pdf

RON3W-roxztE/colourtex.co.in/#a:people
0eGlRkOcUlNI7TKMiYrt9bHGyVKe9w6-k0jt8dJGc#about

solidated_annual.pdf
es-next-two-years-results-boardroom-arunkumar-19499198.htm
%20Science%20Limited.pdf

ports-consolidated-revenue-of-rs-29-096-mn-for-q3-fy-2023-24--302061929.html#:~:text=Glenmark%20Pharma
_Report_2324a.pdf
20AR2022-23%20%281%29.pdf
rma-climbs-after-turnaround-q3-numbers-125021700362_1.html

20FY%202022-23.pdf

w_e83a64cdc8.pdf
w_6ce9daddfa.pdf

als/torrent-pharma-buys-us-firm-bio-pharm/articleshow/62560388.cms?from=mdr
ext=The%20latest%20takeover%20is%20anticipated,85bn).

D%20ANNUAL%20REPORT%202022-23.pdf
are-by-geographic-segment/

fSXd2F3QnBiM/indo-mim.com#a:about
mn-more-in-us-steel-plant-prashant-ruia-125012400502_1.html
ebt-asset-light-business-model-3111113/
hieves-highest-fiscal-revenue/#:~:text=The%20company%20has%20reported%20its,to%20approximately%20

s%20Limited%20-%20India.pdf
mited-India.pdf

23-2024.pdf

ds-to-trends-surya-livings-voyage-from-handwoven-carpets-to-online-dcor-delight/articleshow/108782007.cms
20Carpet%20Private%20Limited/#a:financials

parative-analysis-of-revenue-ebitda-and-pat

2020-21.pdf
ule-supply-order-for-nlc-indias-khavda-solar-project/#:~:text=About%20Vikram%20Solar:,execution)%20and%2

ted-Annual-Report-2022-23.pdf

-limited-annual-report-fy-2022-23-high-resolution-1693199408.pdf
3-24-1721652051.pdf

ual_Report_2022_2023_compressed_1_0f50d6432d.pdf
t-2023-24-2.pdf

ngle_page_view_for_web_upload_140723_compressed_c192bf30c3.pdf
4_high_res_1890c8a8ec.pdf

rt-2023_Final_R1.pdf
t-23-24.pdf
nancial-reporting/annual-report/2021-22/AGM%20Notice%20and%20Annual%20Report%20FY22.pdf
nancial-reporting/annual-report/2022-23/AGM%20Notice%20and%20Annual%20Report%20FY2023.pdf
nancial-reporting/annual-report/2023-24/AGM%20Notice%20and%20Annual%20Report%20FY2024.pdf

0year%202021%20-%202022_762.pdf
0year%202022%20-%202023_1136.pdf
0year%202022%20-%202023_1136.pdf

al-Report-2021-22.pdf
al-Report-2022-23.pdf
al-Report-2023-24.pdf
ber-facility-targets-10-12-market-share/14268

-2023-24.pdf

Divis-Laboratories-Limited.pdf

nnual_Report_2021-22.pdf
nnual-Report-2022-23.pdf
nnual-Report-2023-24.pdf

an-incorporates-subsidiary-in-usa-124022800455_1.html

extiles%20Ltd/Annual_Report_2021-22.pdf
extiles%20Ltd/Annual_Report_2022-23.pdf
extiles%20Ltd/Annual_Report_2023-24.pdf

022/Q1/Alembic-Pharmaceuticals-Limited-Annual-Report-2021-22.pdf
023/Q2/Alembic-Interactive-AR-2023-final-SP-high.pdf
024/Q1/Annual%20Report%202023-2024.pdf

ncials-and-reports/annual-report/latest/neuland-annual-report-fy2022.pdf
ual-Report-neuland-2022-23.pdf
ncials-and-reports/integrated-annual-report-2023-24.pdf

al-Report-2023.pdf

pressed2.pdf
siness,to%20buy%20Mayne%20Pharma%20assets&text=More%20generic%20products%20will%20soon,of%20

uct%20portfolio.

%24550M%20%7C%20Cipla
0technology.%20We%20will%20remain%20focused%20on.

al%20year%202022%2C%20the,of%20the%20COVID%2D19%20pandemic.

anet%20carriers%20made%20from

on-of-strength-of-nature
20Ltd%20will%20be,proximity%20to%20the%20markets%20globally%20and%20bring
xt=Glenmark%20Pharmaceuticals%20Ltd.-,India,Ichnos%20Glenmark%20Innovation%20(IGI)
to%20approximately%20Rs%20700%20crores.

eshow/108782007.cms

ar:,execution)%20and%20over%201900%20employees.
t%20FY22.pdf
t%20FY2023.pdf
t%20FY2024.pdf
s%20will%20soon,of%20up%20to%20$15%20million.
Workable Tracked
Need to work Yet to Track
Does not Fit